SHC

Sotera Health Co

SHC, USA

Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

https://soterahealth.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
SHC
stock
SHC

CEO Share Sale and Secondary Offering Might Change The Case For Investing In Sotera Health (SHC) simplywall.st

Read more →
SHC
stock
SHC

Sotera Health (SHC): Reassessing Valuation After Major Secondary Share Sale and Earnings Beat simplywall.st

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$18.9286

Analyst Picks

Strong Buy

3

Buy

2

Hold

3

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very Low

84.20

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

8.77

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

8.79 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

1.52 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Medium

10.73 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

4.79

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 101.56% of the total shares of Sotera Health Co

1.

Warburg Pincus LLC

(25.9897%)

since

2025/06/30

2.

GTCR LLC

(17.3265%)

since

2025/06/30

3.

Darsana Capital Partners LP

(7.0446%)

since

2025/06/30

4.

Vanguard Group Inc

(5.2493%)

since

2025/06/30

5.

BlackRock Inc

(4.83%)

since

2025/06/30

6.

OZ Management LLC

(4.0486%)

since

2025/06/30

7.

T. Rowe Price Investment Management,Inc.

(3.1873%)

since

2025/06/30

8.

Sachem Head Capital Management LP

(2.7848%)

since

2025/06/30

9.

Sessa Capital IM LP

(2.2182%)

since

2025/06/30

10.

HHG PLC

(2.1311%)

since

2025/06/30

11.

MIG Capital, LLC

(1.8597%)

since

2025/06/30

12.

iShares Core S&P Mid-Cap ETF

(1.7565%)

since

2025/08/31

13.

Vanguard Total Stock Mkt Idx Inv

(1.7449%)

since

2025/07/31

14.

State Street Corp

(1.5975%)

since

2025/06/30

15.

Dimensional Fund Advisors, Inc.

(1.5012%)

since

2025/06/30

16.

Two Seas Capital LP

(1.4156%)

since

2025/06/30

17.

Vanguard Small Cap Index

(1.3336%)

since

2025/07/31

18.

Irenic Capital Management LP

(1.3068%)

since

2025/06/30

19.

Janus Henderson US Opportunistic Alpha

(1.1982%)

since

2025/06/30

20.

Janus Henderson Contrarian D

(1.1982%)

since

2025/06/30

21.

D. E. Shaw & Co LP

(1.0914%)

since

2025/06/30

22.

Lakewood Capital Management, LP

(1.0783%)

since

2025/06/30

23.

Geode Capital Management, LLC

(1.0257%)

since

2025/06/30

24.

T. Rowe Price US Small-Cap Core Equity

(0.9348%)

since

2025/06/30

25.

T. Rowe Price Small-Cap Stock

(0.825%)

since

2025/07/31

26.

Vanguard Small Cap Growth Index Inv

(0.7517%)

since

2025/07/31

27.

Morgan Stanley - Brokerage Accounts

(0.7409%)

since

2025/06/30

28.

Point72 (DIFC) Ltd

(0.6077%)

since

2025/06/30

29.

Vanguard Institutional Extnd Mkt Idx Tr

(0.5792%)

since

2025/07/31

30.

T. Rowe Price Small-Cap Value

(0.5261%)

since

2025/07/31

31.

T. Rowe Price U.S. SC Core Eq Tr-D

(0.456%)

since

2025/06/30

32.

T. Rowe Price Instl Small-Cap Stock

(0.4166%)

since

2025/07/31

33.

SPDR® S&P MIDCAP 400 ETF Trust

(0.4134%)

since

2025/07/31

34.

Janus Henderson Global Life Sciences D

(0.3883%)

since

2025/06/30

35.

Janus Henderson Global Life Sciences

(0.3883%)

since

2025/06/30

36.

T. Rowe Price U.S. SC Value Eq Tr-D

(0.3721%)

since

2025/06/30

37.

Janus Global Life Science AUSD

(0.3265%)

since

2025/06/30

38.

Janus Henderson Glb Life Scn I2 USD

(0.3234%)

since

2025/07/31

39.

DFA US Small Cap I

(0.3043%)

since

2025/07/31

40.

Fidelity Extended Market Index

(0.2916%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.2423

Latest Release

Date

2025-09-30

EPS Actual

0.26

EPS Estimate

0.2167

EPS Difference

0.0433

Surprise Percent

19.9815%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.8)
GARP
Fair GARP(5.5)
Growth
Moderate Growth(5.5)
Momentum
Moderate Momentum(3.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
Moderate Quality(5.5)
Value
Fair Value(3.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.